Compare SpaceX (SPCX) vs 10X Genomics Inc (TXG) Price & Performance

SpaceXTrade

10X Genomics IncTrade

Price performance (Past 24H)

Key statistics

SpaceX vs 10X Genomics Inc — how do they compare? SpaceX trades at $135.71 (market cap $1.76T), while 10X Genomics Inc trades at $59 (market cap $7.61B). The key difference: SpaceX is far larger — about 231.3× 10X Genomics Inc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, SpaceX nearer its low. Which is the better fit depends on your goals.

	SPCX	TXG
Market Cap	$1.76T	$7.61B
Sector	Technology	Health
52-Week High	$202.09	$58.57
52-Week Low	$108.27	$11.34
Enterprise Value	$1.70T	$7.14B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

SPCX

Investor Ron Baron predicts SpaceX could reach a $40 trillion valuation in 15 years, echoing his successful Tesla bet.24/7 Wall Street · 4 hours agoBullish Morgan Stanley values SpaceX's AI software Cursor at $33B ARR by 2030, boosting SpaceX's stock outlook.24/7 Wall Street · 4 hours agoBullish SpaceX IPO boosts securities lending interest in the space sector, fueling diverse investment strategies.Seeking Alpha · 7 hours agoNeutral View details →

TXG

View details →

About SpaceX

SpaceX is the world's leading aerospace manufacturer and launch provider. It designs and operates reusable rockets, spacecraft, and Starlink, a global satellite internet service with over 10 million subscribers across 160 countries.

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.